Financial

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

DUBLIN, Ireland and BRIDGEWATER, N.J. and NANTOU, Taiwan, July 31, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”) today announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® (icosapent ethyl) across 10 countries, including nine in Southeast Asia […]

Society for Vascular Surgery Responds to New York Times Article on Overuse of Interventions in Vascular Surgery

ROSEMONT, Ill., July 31, 2023 /PRNewswire/ — The Society for Vascular Surgery (SVS), the leading medical organization dedicated to advancing quality in vascular health care, has issued a response to a recent New York Times article detailing allegations of overuse of interventions to treat patients with peripheral vascular disease.  SVS sent a strong message that it is inaccurate […]

Argon Medical Devices Recognized as 2023 Top Workplace in Manufacturing

PLANO, Texas, July 28, 2023 /PRNewswire/ — Argon Medical Devices, a leading manufacturer of medical devices for interventional procedures, announces recognition as a 2023 Top Workplace in the USA Manufacturing sector. Recipients of the Top Workplaces awards are selected based on feedback from a research-backed employee engagement survey initiated by technology company, Energage. Top […]

RapidAI Announces $75 Million Growth Investment Led by Vista Credit Partners

SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data […]

TransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary

ANDOVER, Mass., July 26, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the appointment of Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary. “We are excited to welcome Anil […]

BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023

MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational1 basis and 11.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]

EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

IRVINE, Calif., July 26, 2023 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2023. Highlights and Outlook Q2 sales grew 11 percent to $1.53 billion; constant currency1 sales grew 12 percent All product groups achieved double digit constant currency sales growth in Q2 Q2 TAVR sales grew 9 percent; […]

LivaNova Reports Second-Quarter 2023 Results

LONDON–(BUSINESS WIRE)– LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights1 Second-quarter revenue of $293.9 million increased 15.6% on a reported basis and increased 16.4% on a constant-currency basis, as compared to the […]

BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications

Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (“BAIS”), a subsidiary of the […]